Sector ratings 3SBio Inc.

Equities

Market Closed - Hong Kong S.E. Other stock markets 08:08:04 06/02/2026 GMT			5-day change	1st Jan Change
22.94 ^HKD	-0.78%		-1.55%	-5.13%

12-02	3SBio Seeks HK$3.12 Billion via Share Sale	MT
12-02	3SBio to place 105.2 million shares	RE

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
3SBIO INC.	7.33B		AA
REGENERON PHARMACEUTICALS, INC.	80.61B		A
CSL LIMITED	61B		AA
UCB	58.81B		AA
SAMSUNG BIOLOGICS CO.,LTD.	52.77B		BBB
BIOGEN INC.	29.52B		AA
INCYTE CORPORATION	21.28B		AA
INNOVENT BIOLOGICS, INC.	17.65B		AAA
MODERNA, INC.	16.02B	-	A	-		-
SWEDISH ORPHAN BIOVITRUM AB	15.17B		AA
INTRA-CELLULAR THERAPIES, INC.	14.02B	-	BBB	-		-	-
ALTEOGEN INC.	13.2B		CCC
BRIDGEBIO PHARMA, INC.	13.11B	-	BB	-		-
BIOMARIN PHARMACEUTICAL INC.	11.17B		BBB
AVIDITY BIOSCIENCES, INC.	10.98B	-	BB	-		-
AXSOME THERAPEUTICS, INC.	9.2B	-	BB	-		-
GRIFOLS, S.A.	7.82B		BB
KRYSTAL BIOTECH, INC.	7.91B		B			-
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	7.63B	-	B	-		-	-
HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD.	6.18B	-	-	-	-	-	-	-
Average	23.07B		A
Weighted average by Cap.			A